...
首页> 外文期刊>British Journal of Haematology >Higher risk of primary cancers after polycythaemia vera and vice versa
【24h】

Higher risk of primary cancers after polycythaemia vera and vice versa

机译:真性红细胞增多症后原发癌的风险较高,反之亦然

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To our knowledge, there are no population-based epidemio-logical data concerning whether individuals with polycythaemia vera (PV) are at an elevated risk of developing solid tumours and vice versa. This study aimed to systematically quantify the risk of all primary cancers after PV and vice versa for the first time.Since the mid-1950s, patients with haematological disorders in Sweden are primarily diagnosed, treated, and followed clinically by physicians at hospital-based haematology/oncol-ogy centres and each incident case of cancer is reported to the nationwide Swedish Cancer Registry. In Sweden, the criteria for PV diagnosis have changed from those of the Polycythaemia Vera Study Group (mid-1970s-late-1990s) to the World Health Organization criteria (Landgren et al, 2008).
机译:据我们所知,尚无基于人群的流行病学数据,涉及真性红细胞增多症(PV)患者是否患上实体瘤的风险较高,反之亦然。这项研究旨在首次系统地量化PV发生后所有原发癌的风险,反之亦然。自1950年代中期以来,瑞典血液病的患者主要由医院血液病学的医生进行诊断,治疗和临床随访/ oncol-ogy中心,并将每起癌症事件报告给全国瑞典癌症登记处。在瑞典,PV诊断的标准已从真性红细胞增多症研究组(1970年代后期至1990年代)更改为世界卫生组织的标准(Landgren等,2008)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号